Postmarketing studies almost routine in US, Europe and Japan
This article was originally published in Scrip
Executive Summary
Post-approval study commitments are becoming more or less routine in the US, Europe and Japan, says a new study conducted by the Boston-basedTufts Center for the Study of Drug Development.